Soho-Yiming salmon calcitonin API obtained EU CEP certificate
Recently，ShanghaiSoho-Yiming received the Certificate of Suitability to Monograph of EuropeanPharmacopoeia (referred to as "Certificate of Suitability to Monograph ofEuropean Pharmacopoeia") issued by the European Directorate for Quality of Medicines & Health Care (referred to as "EDQM"). "CEPCertificate")
The relevant situation is as follows:
Drug name Calcitonin (Salmon)/Salmon Calcitonin
Product dosage form
Certificate number R0-CEP 2014-229-Rev 00
Issuing agency European Agency for theQuality of Medicines (EDQM)
Salmon Calcitonin is mainly used to treat early and late postmenopausal osteoporosis and Senile Steoporosis.
Salmon Calcitonin CEP certificate is the second peptide APIs CEP certification certificate obtained by Soho-Yiming after Oxytocin. It is the first company in China to pass the European CEP certification of Salmon Calcitonin APIs, and it is also the only domestic Salmon Calcitonin APIs manufacturer that has both China GMP certificate and European certificate.